Shouyao Group is dedicated to the innovation, research, development, production, marketing, health management, and investment In small-molecule peptide solutions. Leveraging biologically active peptide technology, the company conducts in-depth development of traditional medicinal and edible raw materials to produce more efficient and safer biologically active peptide products. over 80 types of small-molecule peptide solutions derived from medicinal and edible sources. After completing its first-phase construction, the company is going to be in full-scale production. Shouyao (Datong) Biotechnology Co., Ltd is capable of producing 2,700 tons of small molecule peptide liquid beverages per year, while Aishi Medical Device Technology (Shanxi) Co., Ltd. is capable of manufacturing 160 tons of small molecule peptide medical devices annually. . Shouyao Group offers product research and development, technical services, and sales to a wide range of food, functional food, and biopharmaceutical enterprises and customers, promoting the scientific development of the traditional Chinese medicine industry. Additionally, the company is in the process of establishing a digital health management system.